For individuals harboring pathogenic variants in SLC16A11, the resulting consequences in lipid metabolism may drive their likelihood of developing diabetes much more so than any effect MAP3K15 may have on glucose uptake or gluconeogenesis. This evidence concerns the gene MAP3K15 and diabetes mellitus.